Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope Orange County, shared on X:
“New Paper on Pharmacokinetics and Pharmacodynamics of localized intra-arterial Gemcitabine.
Advantages:
- Increased tissue concentration.
- Decreased systemic dosing/toxicity.
More pertinent in an era of better systemic.”
Title: Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial
Authors: Paula M. Novelli, Emmanuel E. Zervos, Amer H. Zureikat, Michael J. Pishvaian, Kenneth Meredith, Hassan Hatoum, Reza Nazemzadeh, Sandeep Laroia, Pashtoon Kasi, Justus Bingham, Ramtin Agah
Pashtoon Kasi was recognized among OncoDaily’s ‘Top 100 Xfluencers in Colorectal Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024’, highlighting their contributions to the field of oncology.
Nominations for ‘100 Influential People in Oncology 2026’ are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit Your Nomination by September 15.
